| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.3 |